Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Green Plus JSCHSTC:GPC 32 Revenue per Share is ₫ as of . 20. GuruFocus rates HSTC:GPC with a GF Score™ of 32/100. The stock has 1 warning sign investors should review. Among 906 Drug Manufacturers companies, Green Plus JSC ranks worse than 110375.17% on this metric.
Green Plus JSC's revenue per share for the
six
months ended in . 20 was ₫0.00.
Green Plus JSC does not have enough years/quarters to calculate the revenue per share for the trailing twelve months (TTM) ended in . 20.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Green Plus JSC's Revenue per Share or its related term are showing as below:
HSTC:GPC's 3-Year Revenue Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 3.75 * Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Green Plus JSC Revenue per Share Related Terms
Green Plus JSC Revenue per Share Historical Data
* Premium members only.
The historical data trend for Green Plus JSC's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Plus JSC Revenue per Share Chart
Green Plus JSC Annual Data
Trend
Revenue per Share
Green Plus JSC Semi-Annual Data
Revenue per Share
HSTC:GPC vs ZTS, UTHR, VTRS: Revenue per Share Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Green Plus JSC's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Green Plus JSC PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Green Plus JSC's PS Ratio distribution charts can be found below:
* The bar in red indicates where Green Plus JSC's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Green Plus JSC's Revenue Per Share for the fiscal year that ended in . 20 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Green Plus JSC (HSTC:GPC) has a Revenue per Share of ₫ as of . 20. Revenue per share equals the per-share value of a company's sales. View historical data on Green Plus JSC and its competitors. According to the industry distribution chart, Green Plus JSC ranks #999999 out of 906 companies in the Drug Manufacturers industry.
Is Green Plus JSC's Revenue per Share too high?
Green Plus JSC's current Revenue per Share is ₫. Based on the distribution chart, Green Plus JSC ranks #999999 out of 906 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Green Plus JSC has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Green Plus JSC's Revenue per Share compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Green Plus JSC ranks #999999 out of 906 companies for Revenue per Share. This places Green Plus JSC in the lower half of its industry. The industry median Revenue per Share is 3.75. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Drug Manufacturers company?
The median Revenue per Share among Drug Manufacturers companies is 3.75, based on 906 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Green Plus JSC and its competitors. For the Drug Manufacturers industry, the median Revenue per Share is 3.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Green Plus JSC's current Revenue per Share is ₫. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Green Plus JSC stock overvalued right now?
Green Plus JSC (HSTC:GPC) has a current Revenue per Share of ₫. The current Revenue per Share is ₫. Green Plus JSC's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Green Plus JSC (HSTC:GPC), the current Revenue per Share is ₫ as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Green Plus JSC is engaged in manufacturing and distributing pharmaceutical and herbal products. The Company was established with the mission of improving public health by providing health food products of natural origin, high quality, safe and effective. Company has also chosen to cooperate with a reputable international partner from Japan so that Vietnamese people can use high-quality functional food products at reasonable prices. In addition, Green+ constantly invests in research, product development and service improvement with a team of dedicated and experienced experts to bring truly different values.
32GF Score
Get the complete analysis for HSTC:GPC
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HSTC:GPC has been successfully added to your 
